Background. When combined with ceftazidime, the novel non–β-lactam β-lactamase inhibitor avibactam provides a carbapenem alternative against multidrug-resistant infections. Efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback